查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1434544

制酸剂市场：按剂型、药物类别、通路 - 2024-2030 年全球预测

Antacids Market by Formulation (Liquid, Powder, Tablet), Drug Class (Acid Neutralizers, H2 Antagonist, Promotility Agents), Distribution Channel - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年制酸剂市场规模为78.8亿美元，预计2024年将达82.7亿美元，2030年将达到111.9亿美元，复合年增长率为5.13%。

全球制酸剂市场

主要市场统计
基准年[2023] 78.8亿美元
预测年份 [2024] 82.7亿美元
预测年份 [2030] 111.9亿美元
复合年增长率（%） 5.13%
抗酸剂市场-IMG1

FPNV定位矩阵

FPNV定位矩阵对于评估制酸剂市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对制酸剂市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-制酸剂市场的市场规模与预测是多少？

2-在制酸剂市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些？

3-制酸剂市场的技术趋势和法律规范是什么？

4-制酸剂市场主要供应商的市场占有率是多少？

5-进入制酸剂市场合适的型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 由于不健康的生活方式选择和摄取导致胃酸过多的药物，越来越多的人患有胃食道逆流 (GERD)
      • 增加资讯以提高人们对 GERD 的认识
      • 久坐和压力大的生活方式需要制酸剂
    • 抑制因素
      • 针对酸度相关问题的家庭疗法和其他替代方法的可用性
    • 机会
      • 开发具有更直接和持久效果的制酸剂
      • 在网路药局轻鬆取得制酸剂，成药的监管弹性
    • 任务
      • FDA 因与制酸剂相关的严重健康副作用而召回药物
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章以剂型分類的制酸剂市场

  • 液体
  • 粉末
  • 药片

第七章依药物类别分類的制酸剂市场

  • 酸中和剂
  • H2拮抗剂
  • 促销代理
  • 质子帮浦抑制剂

第八章制酸剂市场：按分销管道

  • 医院药房
  • 零售药房

第九章美洲制酸剂市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太制酸剂市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲/中东/非洲制酸剂市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第13章竞争产品组合

  • 主要公司简介
    • Alardius Healthcare
    • Bayer AG
    • Biozenta Lifescience PVT LTD
    • Boehringer Sohn AG & Ko. KG
    • Cadila Pharmaceuticals Limited
    • GlaxoSmithKline PLC
    • GM Pharmaceuticals, Inc.
    • Johnson & Johnson Services, Inc.
    • Novartis AG
    • Pfizer Inc.
    • Procter and Gamble Company
    • Sanofi-Aventis Groupe SA
    • Torrent Pharmaceuticals Ltd.
    • Uniroyal Biotech
    • WellSpring Pharmaceutical Corporation
  • 主要产品系列

第十四章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-4358BACA7E48

[186 Pages Report] The Antacids Market size was estimated at USD 7.88 billion in 2023 and expected to reach USD 8.27 billion in 2024, at a CAGR 5.13% to reach USD 11.19 billion by 2030.

Global Antacids Market

KEY MARKET STATISTICS
Base Year [2023] USD 7.88 billion
Estimated Year [2024] USD 8.27 billion
Forecast Year [2030] USD 11.19 billion
CAGR (%) 5.13%
Antacids Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Antacids Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antacids Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Antacids Market, highlighting leading vendors and their innovative profiles. These include Alardius Healthcare, Bayer AG, Biozenta Lifescience PVT LTD, Boehringer Sohn AG & Ko. KG, Cadila Pharmaceuticals Limited, GlaxoSmithKline PLC, GM Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Novartis AG, Pfizer Inc., Procter and Gamble Company, Sanofi-Aventis Groupe S.A., Torrent Pharmaceuticals Ltd., Uniroyal Biotech, and WellSpring Pharmaceutical Corporation.

Market Segmentation & Coverage

This research report categorizes the Antacids Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Formulation
    • Liquid
    • Powder
    • Tablet
  • Drug Class
    • Acid Neutralizers
    • H2 Antagonist
    • Promotility Agents
    • Proton Pump Inhibitor
  • Distribution Channel
    • Hospital Pharmacy
    • Retail Pharmacy
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Antacids Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antacids Market?

3. What are the technology trends and regulatory frameworks in the Antacids Market?

4. What is the market share of the leading vendors in the Antacids Market?

5. Which modes and strategic moves are suitable for entering the Antacids Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Antacids Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing population suffering from gastroesophageal reflux disease, or GERD due to unhealthy lifestyle choices and consumption of drugs resulting in acidity
      • 5.1.1.2. Increasing information creating awareness about GERD
      • 5.1.1.3. Sedentary and stressed lifestyle demanding antacids
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of home remedies and other alternatives for acidity related issues
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of more instantly effective and long lasting antacids
      • 5.1.3.2. Easy availability of antacids in the online pharmacy and regulation flexibility for OTC drugs
    • 5.1.4. Challenges
      • 5.1.4.1. FDA drug recall due to significant health side effects associated with the antacids
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Antacids Market, by Formulation

  • 6.1. Introduction
  • 6.2. Liquid
  • 6.3. Powder
  • 6.4. Tablet

7. Antacids Market, by Drug Class

  • 7.1. Introduction
  • 7.2. Acid Neutralizers
  • 7.3. H2 Antagonist
  • 7.4. Promotility Agents
  • 7.5. Proton Pump Inhibitor

8. Antacids Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacy
  • 8.3. Retail Pharmacy

9. Americas Antacids Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Antacids Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Antacids Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Alardius Healthcare
    • 13.1.2. Bayer AG
    • 13.1.3. Biozenta Lifescience PVT LTD
    • 13.1.4. Boehringer Sohn AG & Ko. KG
    • 13.1.5. Cadila Pharmaceuticals Limited
    • 13.1.6. GlaxoSmithKline PLC
    • 13.1.7. GM Pharmaceuticals, Inc.
    • 13.1.8. Johnson & Johnson Services, Inc.
    • 13.1.9. Novartis AG
    • 13.1.10. Pfizer Inc.
    • 13.1.11. Procter and Gamble Company
    • 13.1.12. Sanofi-Aventis Groupe S.A.
    • 13.1.13. Torrent Pharmaceuticals Ltd.
    • 13.1.14. Uniroyal Biotech
    • 13.1.15. WellSpring Pharmaceutical Corporation
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ANTACIDS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTACIDS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ANTACIDS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANTACIDS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ANTACIDS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANTACIDS MARKET DYNAMICS
  • FIGURE 7. ANTACIDS MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 8. ANTACIDS MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ANTACIDS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
  • FIGURE 10. ANTACIDS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 12. ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ANTACIDS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ANTACIDS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ANTACIDS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. ANTACIDS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ANTACIDS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ANTACIDS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTACIDS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 6. ANTACIDS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANTACIDS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANTACIDS MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 10. ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ANTACIDS MARKET SIZE, BY H2 ANTAGONIST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ANTACIDS MARKET SIZE, BY PROMOTILITY AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ANTACIDS MARKET SIZE, BY PROTON PUMP INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 15. ANTACIDS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ANTACIDS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ANTACIDS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. ANTACIDS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 145. ANTACIDS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. ANTACIDS MARKET LICENSE & PRICING